ALMS
Price
$3.88
Change
+$0.02 (+0.52%)
Updated
Jul 25 closing price
Capitalization
400.37M
23 days until earnings call
CCCC
Price
$2.26
Change
-$0.03 (-1.31%)
Updated
Jul 25 closing price
Capitalization
160.48M
10 days until earnings call
Interact to see
Advertisement

ALMS vs CCCC

Header iconALMS vs CCCC Comparison
Open Charts ALMS vs CCCCBanner chart's image
Alumis
Price$3.88
Change+$0.02 (+0.52%)
Volume$660.81K
Capitalization400.37M
C4 Therapeutics
Price$2.26
Change-$0.03 (-1.31%)
Volume$570.53K
Capitalization160.48M
ALMS vs CCCC Comparison Chart in %
Loading...
ALMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALMS vs. CCCC commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALMS is a StrongBuy and CCCC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ALMS: $3.88 vs. CCCC: $2.26)
Brand notoriety: ALMS and CCCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALMS: 70% vs. CCCC: 40%
Market capitalization -- ALMS: $400.37M vs. CCCC: $160.48M
ALMS [@Biotechnology] is valued at $400.37M. CCCC’s [@Biotechnology] market capitalization is $160.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALMS’s FA Score shows that 1 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • ALMS’s FA Score: 1 green, 4 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, CCCC is a better buy in the long-term than ALMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALMS’s TA Score shows that 3 TA indicator(s) are bullish while CCCC’s TA Score has 6 bullish TA indicator(s).

  • ALMS’s TA Score: 3 bullish, 3 bearish.
  • CCCC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than ALMS.

Price Growth

ALMS (@Biotechnology) experienced а +16.52% price change this week, while CCCC (@Biotechnology) price change was -2.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ALMS is expected to report earnings on Aug 19, 2025.

CCCC is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALMS($400M) has a higher market cap than CCCC($160M). CCCC YTD gains are higher at: -37.222 vs. ALMS (-50.636). CCCC has higher annual earnings (EBITDA): -102.74M vs. ALMS (-354.69M). CCCC (215M) and ALMS (209M) have equal amount of cash in the bank . ALMS has less debt than CCCC: ALMS (31.9M) vs CCCC (64.4M). CCCC has higher revenues than ALMS: CCCC (39.8M) vs ALMS (17.4M).
ALMSCCCCALMS / CCCC
Capitalization400M160M250%
EBITDA-354.69M-102.74M345%
Gain YTD-50.636-37.222136%
P/E RatioN/AN/A-
Revenue17.4M39.8M44%
Total Cash209M215M97%
Total Debt31.9M64.4M50%
TECHNICAL ANALYSIS
Technical Analysis
ALMSCCCC
RSI
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ALMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRLAF5.19N/A
N/A
British Land Company (The) PLC
LNCLF0.12N/A
N/A
Lincoln Gold Mng Inc.
TNYZF0.67N/A
-0.10%
Tiny Ltd.
VONOY16.14-0.24
-1.47%
VONOVIA SE
CNAF6.72-0.28
-4.00%
Commercial National Financial Corp. (PA)

ALMS and

Correlation & Price change

A.I.dvisor tells us that ALMS and ADAP have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALMS and ADAP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALMS
1D Price
Change %
ALMS100%
+0.52%
ADAP - ALMS
30%
Poorly correlated
+19.62%
SLNO - ALMS
28%
Poorly correlated
-1.77%
CCCC - ALMS
27%
Poorly correlated
-1.31%
ATXS - ALMS
27%
Poorly correlated
+1.37%
KRRO - ALMS
26%
Poorly correlated
+0.69%
More

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-1.31%
BEAM - CCCC
54%
Loosely correlated
+3.68%
CRBU - CCCC
51%
Loosely correlated
-3.80%
KYMR - CCCC
51%
Loosely correlated
-0.13%
IDYA - CCCC
50%
Loosely correlated
-1.33%
SYRE - CCCC
50%
Loosely correlated
+1.08%
More